Articles with public access mandates - Joshua B RubinLearn more
OverallNIHCIHRSwedish Research CouncilGenome CanadaCCSCancer Research UKWellcomeOICRNSFAmerican Brain Tumor AssociationDoDMTAWorldwide Cancer Research, UKV Foundation, USAChildren's Tumor Foundation, USAVAAHAFRQSNSERCUSDANSFCDNRFOTKAMRCState of CalifoniaGovernment of SpainPCORIAIRC Foundation for Cancer Research in ItalyBrain Tumour Charity, UKFlorida Department of Health, USACPRITCarlsberg Foundation DKGovernment of Argentina
Not available anywhere: 1
LeMoyne Habimana-Griffin Dezhuang Ye Julia Carpenter Julie Prior
G Sudlow, L Marsala, M Mixdorf, JB Rubin, H Chen, S Achilefu
Journal of Biomedical Optics 26004, 1, 2020
Mandates: US Department of Defense, US National Institutes of Health
Available somewhere: 120
Sex and gender: modifiers of health, disease, and medicine
F Mauvais-Jarvis, NB Merz, PJ Barnes, RD Brinton, JJ Carrero, ...
The Lancet 396 (10250), 565-582, 2020
Mandates: US National Institutes of Health, US Department of Veterans Affairs, Swedish …
Intertumoral heterogeneity within medulloblastoma subgroups
FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ...
Cancer cell 31 (6), 737-754. e6, 2017
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ...
Nature 488 (7409), 49-56, 2012
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
Z Zeng, Y Xi Shi, IJ Samudio, RY Wang, X Ling, O Frolova, M Levis, ...
Blood, The Journal of the American Society of Hematology 113 (24), 6215-6224, 2009
Mandates: US National Institutes of Health
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ...
Journal of Clinical Oncology 31 (23), 2927-2935, 2013
Mandates: US National Institutes of Health, Cancer Research UK
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor
SN Chi, MA Zimmerman, X Yao, KJ Cohen, P Burger, JA Biegel, ...
Journal of clinical oncology 27 (3), 385-389, 2009
Mandates: US National Institutes of Health
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
AM Fontebasso, S Papillon-Cavanagh, J Schwartzentruber, H Nikbakht, ...
Nature genetics 46 (5), 462-466, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
EM Thompson, T Hielscher, E Bouffet, M Remke, B Luu, S Gururangan, ...
The lancet oncology 17 (4), 484-495, 2016
Mandates: US National Institutes of Health, Canadian Cancer Society, Canadian …
Cytogenetic prognostication within medulloblastoma subgroups
DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ...
Journal of clinical oncology 32 (9), 886-896, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
W Yang, NM Warrington, SJ Taylor, P Whitmire, E Carrasco, KW Singleton, ...
Science translational medicine 11 (473), eaao5253, 2019
Mandates: US National Institutes of Health
Sex differences in cancer mechanisms
JB Rubin, JS Lagas, L Broestl, J Sponagel, N Rockwell, G Rhee, ...
Biology of sex Differences 11, 1-29, 2020
Mandates: US National Science Foundation, US National Institutes of Health, American …
An integrative view on sex differences in brain tumors
T Sun, A Plutynski, S Ward, JB Rubin
Cellular and molecular life sciences 72, 3323-3342, 2015
Mandates: US National Institutes of Health
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ...
Acta neuropathologica 126, 917-929, 2013
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Sex disparities matter in cancer development and therapy
S Haupt, F Caramia, SL Klein, JB Rubin, Y Haupt
Nature Reviews Cancer 21 (6), 393-407, 2021
Mandates: US National Institutes of Health, American Brain Tumor Association
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma
H Suzuki, SA Kumar, S Shuai, A Diaz-Navarro, A Gutierrez-Fernandez, ...
Nature 574 (7780), 707-711, 2019
Mandates: US National Institutes of Health, Canadian Cancer Society, Canadian …
Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1
KA Diggs‐Andrews, JA Brown, SM Gianino, JB Rubin, DF Wozniak, ...
Annals of neurology 75 (2), 309-316, 2014
Mandates: US National Institutes of Health
Females have the survival advantage in glioblastoma
QT Ostrom, JB Rubin, JD Lathia, ME Berens, JS Barnholtz-Sloan
Neuro-oncology 20 (4), 576-577, 2018
Mandates: US National Institutes of Health
Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males
T Sun, NM Warrington, J Luo, MD Brooks, S Dahiya, SC Snyder, ...
The Journal of clinical investigation 124 (9), 4123-4133, 2014
Mandates: US National Institutes of Health, Children's Tumor Foundation, USA
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS
JR Patel, JL Williams, MM Muccigrosso, L Liu, T Sun, JB Rubin, RS Klein
Acta neuropathologica 124, 847-860, 2012
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program